Northern Trust’s SQZ Biotechnologies Company SQZ Stock Holding History

Northern Trust’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-31,022	Closed	-$8.38K	–	4608
2023 Q2	$8.38K	Hold	31,022	–	–	﹤0.01%	4488
2023 Q1	$17.4K	Hold	31,022	–	–	﹤0.01%	4471
2022 Q4	$23K	Hold	31,022	–	–	﹤0.01%	4463
2022 Q3	$71K	Hold	31,022	–	–	﹤0.01%	4224
2022 Q2	$99K	Sell	31,022 -150,515	-83%	-$542K	﹤0.01%	4173
2022 Q1	$873K	Sell	181,537 -13,131	-7%	-$83.4K	﹤0.01%	3487
2021 Q4	$1.74M	Buy	194,668 +32	+0%	+$392	﹤0.01%	3291
2021 Q3	$2.81M	Buy	194,636 +10,962	+6%	+$149K	﹤0.01%	3096
2021 Q2	$2.65M	Buy	183,674 +119,662	+187%	+$1.56M	﹤0.01%	3223
2021 Q1	$875K	Buy	64,012 +9,304	+17%	+$189K	﹤0.01%	3639
2020 Q4	$1.59M	Buy	+54,708	New	+$1.4M	﹤0.01%	3306

Other funds holding SQZ

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Northern Trust's SQZ Position: Q3 2023 in Review

Northern Trust sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 31,022 shares — an estimated $8.38K sold.

Northern Trust first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $2.81M in Q3 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

Northern Trust reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
Northern Trust sold 31,022 SQZ Biotechnologies Company shares in Q3 2023, an estimated $8.38K.
Northern Trust first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
Northern Trust's SQZ Biotechnologies Company position peaked at $2.81M in Q3 2021.
5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.